Inventor · disambiguated record
John Robert Porter
Also filed as: PORTER JOHN R · PORTER JOHN ROBERT
67 granted patents·12 pending applications·676 citations·filing 1991–2025
99Inventor score
Files withCELLTECH R&D LTD19UCB BIOPHARMA SPRL18UCB Biopharma SRL14CELLTECH THERAPEUTICS LTD11UCB PHARMA SA7
Top patents by PatentIndex Score
79 records- 0196US10705094B2TNF receptor signaling modulator assayUCB Biopharma SRL·Filed 2015·Granted Jul 7, 2020·9 cites·18 claims
- 0295US10883996B2Methods of identifying signaling modulators of the trimeric TNFaUCB Biopharma SRL·Filed 2015·Granted Jan 5, 2021·7 cites·5 claims
- 0395US6369229B1Pyridylalanine derivativesCELLTECH THERAPEUTICS LTD·Filed 2000·Granted Apr 9, 2002·83 cites·9 claims
- 0495US5608070AEnantioselective process for the preparation of chiral triaryl derivatives and chiral intermediates for use thereinCELLTECH THERAPEUTICS LTD·Filed 1994·Granted Mar 4, 1997·70 cites·16 claims
- 0593US11448655B2Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptorsUCB Biopharma SRL·Filed 2020·Granted Sep 20, 2022·2 cites·17 claims
- 0693US11022614B2Antibodies binding to trimeric TNF alpha epitopesUCB Biopharma SRL·Filed 2015·Granted Jun 1, 2021·5 cites·17 claims
- 0793US10969393B2Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding themUCB Biopharma SRL·Filed 2015·Granted Apr 6, 2021·5 cites·11 claims
- 0893US10775385B2Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimersUCB BIOPHARMA SPRL·Filed 2015·Granted Sep 15, 2020·7 cites·4 claims
- 0993US6518283B1Squaric acid derivativesCELLTECH R&D LTD·Filed 2000·Granted Feb 11, 2003·64 cites·22 claims
- 1092US11674967B2Method of identifying potential inhibitors of APO TNFα trimersUCB Biopharma SRL·Filed 2020·Granted Jun 13, 2023·2 cites·19 claims
- 1189US9969728B2Tetrahydroimidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted May 15, 2018·14 cites·7 claims
- 1289US2025012807A1Mechanism of actionUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 1388US12055549B2Methods of use of anti-TNFα antibodiesUCB Biopharma SRL·Filed 2021·Granted Aug 6, 2024·1 cites·16 claims
- 1487US9868749B2Fused imidazole and pyrazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jan 16, 2018·16 cites·7 claims
- 1587US6878718B2Phenylalanine enamide derivativesCELLTECH R&D LTD·Filed 2002·Granted Apr 12, 2005·17 cites·8 claims
- 1686US11174311B2Antibody against trimeric TNFα complexUCB Biopharma SRL·Filed 2017·Granted Nov 16, 2021·4 cites·14 claims
- 1785US12474348B2Complexes between CD40 and compounds comprising benzimidazole moietiesUCB Biopharma SRL·Filed 2022·Granted Nov 18, 2025·0 cites·6 claims
- 1885US9873703B2Imidazopyridazine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jan 23, 2018·8 cites·8 claims
- 1985US6110945AAromatic amine derivativesCELLTECH THERAPEUTICS LTD·Filed 1999·Granted Aug 29, 2000·57 cites·10 claims
- 2084US6677339B2Phenylalanine derivativesCELLTECH R&D LTD·Filed 2001·Granted Jan 13, 2004·19 cites·10 claims
- 2183US7910618B2Albumin-binding conjugates comprising a fatty acid and PEGUCB PHARMA SA·Filed 2005·Granted Mar 22, 2011·2 cites·15 claims
- 2281US7501437B2Phenylalanine enamide derivativesUCB PHARMA SA·Filed 2007·Granted Mar 10, 2009·3 cites·24 claims
- 2380US7122556B2Phenylalanine enamide derivativesCELLTECH R&D LTD·Filed 2004·Granted Oct 17, 2006·9 cites·25 claims
- 2480US6610700B2Enamine derivativesCELLTECH R&D LTD·Filed 2001·Granted Aug 26, 2003·13 cites·11 claims
- 2577US9550737B2TNF -α modulating benzimidazolesUCB BIOPHARMA SPRL·Filed 2013·Granted Jan 24, 2017·4 cites·10 claims
- 2677US6362204B1Phenylalanine derivativesCELLTECH THERAPEUTICS LTD·Filed 1999·Granted Mar 26, 2002·21 cites·9 claims
- 2777US2021140972A1Mechanism of actionUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 2877US2021132079A1AntibodyUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 2976US7645770B2Phenylalanine enamide derivativesUCB PHARMA SA·Filed 2008·Granted Jan 12, 2010·1 cites·21 claims
- 3076US6780874B2Enamine derivativesCELLTECH R&D LTD·Filed 2003·Granted Aug 24, 2004·8 cites·20 claims
- 3176US2025270308A1Antibody epitopeUCB Biopharma SRL·Filed 2025·Application pending·0 cites
- 3275US9309243B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2013·Granted Apr 12, 2016·4 cites·11 claims
- 3375US7786177B2Phenylalanine enamide derivativesUCB PHARMA SA·Filed 2009·Granted Aug 31, 2010·1 cites·23 claims
- 3475US7531549B2Phenylalanine enamide derivativesUCB PHARMA SA·Filed 2006·Granted May 12, 2009·1 cites·24 claims
- 3574US9926313B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Mar 27, 2018·2 cites·8 claims
- 3674US9475820B2Substituted imidazo[1,2-a]pyrazines as TNF activity modulatorsUCB BIOPHARMA SPRL·Filed 2013·Granted Oct 25, 2016·3 cites·14 claims
- 3772US6348463B1Phenylalanine derivativesCELLTECH THERAPEUTICS LTD·Filed 1999·Granted Feb 19, 2002·28 cites·12 claims
- 3872US6329372B1Phenylalanine derivativesCELLTECH THERAPEUTICS LTD·Filed 1999·Granted Dec 11, 2001·27 cites·19 claims
- 3971US8053564B2Cross-linked antibodiesUCB PHARMA SA·Filed 2005·Granted Nov 8, 2011·1 cites·4 claims
- 4070US9969729B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted May 15, 2018·1 cites·5 claims
- 4170US9890154B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Feb 13, 2018·1 cites·5 claims
- 4269US10093652B2Tetrahydrobenzimidazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Oct 9, 2018·1 cites·5 claims
- 4369US9988383B2Purine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jun 5, 2018·1 cites·6 claims
- 4469US9932342B2Imidazopyrimidine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Apr 3, 2018·1 cites·6 claims
- 4569US9920052B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Mar 20, 2018·1 cites·14 claims
- 4669US9834553B2Tetrahydroimidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Dec 5, 2017·1 cites·5 claims
- 4769US2022025033A1Antibody epitopeUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 4868US9932334B2Tetrahydroimidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Apr 3, 2018·1 cites·5 claims
- 4968US9714251B2Imidazotriazine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jul 25, 2017·1 cites·9 claims
- 5067US6455539B2Squaric acid derivatesCELLTECH R&D LTD·Filed 2000·Granted Sep 24, 2002·4 cites·19 claims
Showing the top 50 of 79 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →